See the DrugPatentWatch profile for Lisinopril
What inactive ingredients are in Lisinopril?
Lisinopril tablets contain several inactive ingredients that help form the tablet and ensure its stability. These inactive ingredients, also known as excipients, can vary slightly depending on the manufacturer. Common inactive ingredients found in lisinopril formulations include:
* Calcium phosphate dibasic: This is a filler and binder.
* Corn starch: Used as a disintegrant, helping the tablet break apart in the digestive system, and as a filler.
* Magnesium stearate: This is a lubricant, preventing the tablet from sticking to manufacturing equipment.
* Microcrystalline cellulose: Acts as a binder and filler.
* Povidone: A binder that helps hold the tablet together.
Some lisinopril formulations may also include specific colorants. For example, the white lisinopril tablets often contain no colorants, while other colored tablets may include iron oxides or other approved dyes to differentiate strengths [1].
Why do different lisinopril brands have different inactive ingredients?
Pharmaceutical manufacturers must follow strict regulations when selecting inactive ingredients, ensuring they are safe and do not affect the drug's efficacy or stability. However, there is some flexibility within these guidelines. Different companies may choose slightly different excipients based on factors such as manufacturing processes, cost, availability, and patent considerations for specific formulations. This variation is why some individuals might react differently to generic lisinopril products from different manufacturers, even though the active ingredient, lisinopril, is the same [2].
Can inactive ingredients cause side effects?
While inactive ingredients are generally considered inert and safe, a small number of individuals can have sensitivities or allergies to specific excipients. If a patient experiences an unexpected reaction after starting a new lisinopril product, it is important to discuss this with their healthcare provider. They can help determine if an ingredient in the inactive formulation might be the cause, and if necessary, a prescription for a different brand or formulation could be considered [2].
How are inactive ingredients regulated?
Inactive ingredients are subject to review and approval by regulatory agencies such as the U.S. Food and Drug Administration (FDA). Manufacturers must demonstrate that these components are safe for their intended use and do not compromise the quality, safety, or effectiveness of the final drug product. The FDA maintains lists of acceptable inactive ingredients and their maximum allowable levels in different dosage forms [3].
Where can I find patent information for Lisinopril?
Patent information for lisinopril and its various formulations, including details on exclusivity periods and potential patent challenges, can be found on resources like DrugPatentWatch.com. This site tracks drug patents, expiration dates, and related legal and commercial activities, which can be crucial for understanding market entry timelines for generic versions [4].